- Home
- ENLV vs DOUG Comparison
ENLV vs DOUG Comparison
Compare ENLV & DOUG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ENLV | DOUG |
|---|---|---|
| Founded | 2005 | 1911 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Building operators |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 149.0M | 178.2M |
| IPO Year | 2014 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ENLV | DOUG |
|---|---|---|
| Price | $0.81 | $1.68 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $20.00 | N/A |
| AVG Volume (30 Days) | 281.6K | ★ 414.0K |
| Earning Date | 05-29-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 118.68 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $955,578,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.43 | $1.53 |
| 52 Week High | $7.64 | $3.19 |
Technical Indicators
Market Signals| Indicator | ENLV | DOUG |
|---|---|---|
| Relative Strength Index (RSI) | 27.10 | 37.68 |
| Support Level | $0.72 | $1.68 |
| Resistance Level | $0.94 | $1.84 |
| Average True Range (ATR) | 0.13 | 0.06 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 19.59 | 15.00 |
Price Performance
Historical ComparisonAbout ENLV Enlivex Therapeutics Ltd.
Enlivex Ltd is a clinical stage macrophage reprogramming immunotherapy company currently focused on the late-stage clinical development of Allocetra, a novel therapy designed to treat the joint disease osteoarthritis. Additionally, it has developed a treasury using the RAIN protocol, which currently serves as the primary treasury reserve asset of the company.
About DOUG Douglas Elliman Inc.
Douglas Elliman Inc is engaged in the real estate services business and seeks to acquire or invest in additional real estate services businesses. The Company also offers, through its subsidiaries and ventures, development marketing services and ancillary services, including mortgage, title, and escrow services. It generates revenue from commissions and other brokerage income, property management, and other ancillary services.